Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jinhai International Group Holdings Limited ( (HK:2225) ) has issued an update.
Jinhai Medical Technology Limited announced the signing of three Subscription Agreements with independent private investors to issue a total of 120,000,000 new shares at a price of HK$1.35 per share. This move, under the General Mandate, represents a strategic effort to raise capital without requiring shareholder approval, potentially impacting the company’s market positioning by increasing its share capital by approximately 2.27%. The subscription price reflects a discount to recent market prices, indicating a strategic decision to attract investment under current market conditions.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 3,906,656
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$8.48B
Learn more about 2225 stock on TipRanks’ Stock Analysis page.